ALPHATEC HOLDINGS INC (NASDAQ: ATEC)

ALPHATEC HOLDINGS INC

NASDAQ: ATEC (Alphatec Holdings, Inc.)

Last update: 02 Feb, 9:39PM

14.49

-0.34 (-2.29%)

Add to watchlist

Previous Close	14.83
Open	15.09
Volume	3,363,103
Avg. Volume (3M)	2,759,105
Market Cap	2,152,492,288

Price / Earnings (Forward)	65.79
Price / Sales	2.74
Price / Book	173.91

52 Weeks Range	8.81 (-39%) — 23.29 (60%)
Earnings Date	24 Feb 2026

Market Trend

		Short Term	Medium Term
Industry	Medical Devices (US)	Mixed	Bearish
	Medical Devices (Global)	Mixed	Bearish
Stock	Alphatec Holdings, Inc.	Bullish	Bullish

AIStockmoo Score

1.1

Analyst Consensus	3.0
Insider Activity	1.5
Price Volatility	-1.0
Technical Moving Averages	2.5
Technical Oscillators	-0.5
Average	1.10

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
ATEC	2 B	-	-	173.91
MASI	8 B	-	-	11.30
BRKR	6 B	0.50%	-	2.93
LIVN	4 B	-	-	3.21
TNDM	2 B	-	-	9.67
AXGN	2 B	-	-	7.33

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Sector	Healthcare
Industry	Medical Devices
Investment Style	Small Core
% Held by Insiders	21.42%
% Held by Institutions	63.24%

52 Weeks Range	8.81 (-39%) — 23.29 (60%)
Price Target Range	22.00 (51%) — 27.00 (86%)
High	27.00 (Barclays, 86.34%)	Buy
Median	24.50 (69.08%)
Low	22.00 (Needham, 51.83%)	Buy
Average	24.50 (69.08%)
Total	4 Buy
Avg. Price @ Call	19.27

Firm	Date	Target Price	Call	Price @ Call
HC Wainwright & Co.	12 Jan 2026	24.00 (65.63%)	Buy	17.59
Needham	12 Jan 2026	22.00 (51.83%)	Buy	17.59
Barclays	07 Jan 2026	27.00 (86.34%)	Buy	21.97
Freedom Capital Markets	11 Dec 2025	25.00 (72.53%)	Buy	19.91

Name	Avg. Buy ($)	Avg. Sell ($)	Net Quantity	Net Value ($)
HUNSAKER CRAIG E	14.04	-	459,480	6,451,099
KONING JOHN TODD	14.04	-	335,868	4,715,587
LISH SCOTT	14.04	-	459,480	6,451,099
MARSHALL TYSON ELIOT	14.04	-	302,852	4,252,042
MILES PATRICK	14.04	-	966,293	13,566,754
SPONSEL DAVID	14.04	-	318,884	4,477,131
Aggregate Net Quantity				2,842,857
Aggregate Net Value ($)				39,913,712
Aggregate Avg. Buy ($)				14.04
Aggregate Avg. Sell ($)				-

Name	Holder	Date	Type	Quantity	Price	Value ($)
HUNSAKER CRAIG E	Officer	25 Feb 2026	Acquired (+)	459,480	14.04	6,451,099
LISH SCOTT	Officer	25 Feb 2026	Acquired (+)	459,480	14.04	6,451,099
MILES PATRICK	Officer	25 Feb 2026	Acquired (+)	966,293	14.04	13,566,754
KONING JOHN TODD	Officer	25 Feb 2026	Acquired (+)	335,868	14.04	4,715,587
SPONSEL DAVID	Officer	25 Feb 2026	Acquired (+)	318,884	14.04	4,477,131
MARSHALL TYSON ELIOT	Officer	25 Feb 2026	Acquired (+)	302,852	14.04	4,252,042

Date	Type	Details
12 Jan 2026	Announcement	ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
12 Jan 2026	Announcement	ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2026	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	-25.77%
Operating Margin (TTM)	-18.74%
Diluted EPS (TTM)	-1.14
Quarterly Revenue Growth (YOY)	22.20%

Total Debt/Equity (MRQ)	6,465.30%
Current Ratio (MRQ)	2.76
Operating Cash Flow (TTM)	-11.25 M
Levered Free Cash Flow (TTM)	-24.32 M

Return on Assets (TTM)	-9.33%
Return on Equity (TTM)	-291.71%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)